Compare ARK Genomic Revolution ETF (ARKG) vs Coupang Inc (CPNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Coupang Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Coupang Inc trades at $18.76 (market cap $33.75B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CPNG | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $33.53 |
52-Week Low | $23.09 | $15.12 |
Market Cap | — | $33.75B |
Enterprise Value | — | $32.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Coupang (CPNG) trades at $18.80, down 1.88% on the day, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $34.53B in 2025, though net income margins remain thin at 0.6%. The stock faces headwinds from a recent $409 million regulatory fine in South Korea over a data breach, as reported by Reuters on June 10, 2026, but maintains strong analyst support with 14 buy ratings.
The outlook is cautiously optimistic given Wall Street's $25.80 price target, implying 37% upside, but risks include regulatory scrutiny and volatile earnings. Positive cash flow from operations of $1.77B in 2025 supports growth initiatives, yet investors must weigh competitive pressures in e-commerce against the company's scale advantages.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →
